More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia (Q33520407)

27 July 2017

1 reference

title

More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia (English)

1 reference

intraepithelial neoplasia

27 July 2017

1 reference

M Mahto

1

1 reference

27 July 2017

M Nathan

series ordinal

2

1 reference

27 July 2017

C O'Mahony

series ordinal

3

1 reference

27 July 2017

1 January 2010

1 reference

International Journal of STD & AIDS

27 July 2017

1 reference

27 July 2017

21

1 reference

27 July 2017

1

1 reference

27 July 2017

8-16

1 reference

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

27 July 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Topical immunomodulators--progress towards treating inflammation, infection, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Bowenoid papulosis of the vulva—immunotherapeutical approach with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful treatment of vulvar Bowen's disease with topical imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful topical immunotherapy of bowenoid papulosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of Bowen's disease and erythroplasia of Queyrat

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

[Multifocal penile intraepithelial neoplasia--targeted treatment with imiquimod].

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Bowenoid papulosis at the site of prior herpes progenitalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of Bowen's disease of the penis with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Topical treatment of intraepithelial penile carcinoma with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of Bowen's disease of the penis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful treatment of perianal Bowen's disease with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Diagnosis and management of vulvar and vaginal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Anal intraepithelial neoplasia and anal cancer in dermatological practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009309

21 January 2018

Identifiers

DOI

10.1258/IJSA.2009.009309

1 reference

release_dhhvviothbah7m2jgldrajblxm

27 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dhhvviothbah7m2jgldrajblxm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference